25 XP   0   0   10

Caplin Point Laboratories Limited
Buy, Hold or Sell?

Let's analyse Caplin Point Laboratories Limited together

PenkeI guess you are interested in Caplin Point Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Caplin Point Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Caplin Point Laboratories Limited

I send you an email if I find something interesting about Caplin Point Laboratories Limited.

Quick analysis of Caplin Point Laboratories Limited (30 sec.)










What can you expect buying and holding a share of Caplin Point Laboratories Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.19
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
INR249.29
Expected worth in 1 year
INR455.61
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR222.17
Return On Investment
16.4%

For what price can you sell your share?

Current Price per Share
INR1,355.50
Expected price per share
INR1,240 - INR1,410
How sure are you?
50%

1. Valuation of Caplin Point Laboratories Limited (5 min.)




Live pricePrice per Share (EOD)

INR1,355.50

Intrinsic Value Per Share

INR105.16 - INR408.19

Total Value Per Share

INR354.46 - INR657.48

2. Growth of Caplin Point Laboratories Limited (5 min.)




Is Caplin Point Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$228.8m$181.1m$47.6m20.8%

How much money is Caplin Point Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money$45.1m$35.9m$9.1m20.3%
Net Profit Margin25.7%23.7%--

How much money comes from the company's main activities?

3. Financial Health of Caplin Point Laboratories Limited (5 min.)




What can you expect buying and holding a share of Caplin Point Laboratories Limited? (5 min.)

Welcome investor! Caplin Point Laboratories Limited's management wants to use your money to grow the business. In return you get a share of Caplin Point Laboratories Limited.

What can you expect buying and holding a share of Caplin Point Laboratories Limited?

First you should know what it really means to hold a share of Caplin Point Laboratories Limited. And how you can make/lose money.

Speculation

The Price per Share of Caplin Point Laboratories Limited is INR1,356. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Caplin Point Laboratories Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Caplin Point Laboratories Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR249.29. Based on the TTM, the Book Value Change Per Share is INR51.58 per quarter. Based on the YOY, the Book Value Change Per Share is INR40.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR3.96 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Caplin Point Laboratories Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.590.0%0.590.0%0.470.0%0.410.0%0.260.0%
Usd Book Value Change Per Share0.620.0%0.620.0%0.480.0%0.480.0%0.290.0%
Usd Dividend Per Share0.050.0%0.050.0%0.040.0%0.030.0%0.020.0%
Usd Total Gains Per Share0.670.0%0.670.0%0.520.0%0.520.0%0.310.0%
Usd Price Per Share7.15-7.15-8.14-5.67-6.43-
Price to Earnings Ratio12.12-12.12-17.27-13.88-48.75-
Price-to-Total Gains Ratio10.73-10.73-15.77-11.14-50.37-
Price to Book Ratio2.39-2.39-3.43-3.09-18.03-
Price-to-Total Gains Ratio10.73-10.73-15.77-11.14-50.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share16.266
Number of shares61
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.03
Usd Book Value Change Per Share0.620.48
Usd Total Gains Per Share0.670.52
Gains per Quarter (61 shares)40.6631.47
Gains per Year (61 shares)162.63125.89
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1121511538118116
22330231616236242
33545347924354368
44660464232472494
55875580540590620
67090696848708746
7811057113156826872
8931208129464943998
9104135914577210611124
10116151016208011791250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%9.00.07.056.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%

Fundamentals of Caplin Point Laboratories Limited

About Caplin Point Laboratories Limited

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. It provides liquid and lyophilized vials, pre-filled syringes, 3-pc ophthalmic droppers, pre-mix bags, dry and liquid syrups-bottles, tables, soft gels, capsules, suppositories, liquid and emulsion injectables in ampoules and vials, topicals, and sachets. The company was incorporated in 1990 and is headquartered in Chennai, India.

Fundamental data was last updated by Penke on 2024-04-13 22:25:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Caplin Point Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Caplin Point Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Caplin Point Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 25.7% means that ₹0.26 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Caplin Point Laboratories Limited:

  • The MRQ is 25.7%. The company is making a huge profit. +2
  • The TTM is 25.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ25.7%TTM25.7%0.0%
TTM25.7%YOY23.7%+1.9%
TTM25.7%5Y24.9%+0.7%
5Y24.9%10Y22.6%+2.3%
1.1.2. Return on Assets

Shows how efficient Caplin Point Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Caplin Point Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 17.2% Return on Assets means that Caplin Point Laboratories Limited generated ₹0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Caplin Point Laboratories Limited:

  • The MRQ is 17.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 17.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.2%TTM17.2%0.0%
TTM17.2%YOY17.3%-0.1%
TTM17.2%5Y19.0%-1.8%
5Y19.0%10Y20.0%-1.0%
1.1.3. Return on Equity

Shows how efficient Caplin Point Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Caplin Point Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 20.0% Return on Equity means Caplin Point Laboratories Limited generated ₹0.20 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Caplin Point Laboratories Limited:

  • The MRQ is 20.0%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 20.0%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.0%TTM20.0%0.0%
TTM20.0%YOY20.2%-0.2%
TTM20.0%5Y22.2%-2.2%
5Y22.2%10Y31.4%-9.1%

1.2. Operating Efficiency of Caplin Point Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Caplin Point Laboratories Limited is operating .

  • Measures how much profit Caplin Point Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Caplin Point Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 30.8% means the company generated ₹0.31  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Caplin Point Laboratories Limited:

  • The MRQ is 30.8%. The company is operating very efficient. +2
  • The TTM is 30.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ30.8%TTM30.8%0.0%
TTM30.8%YOY30.5%+0.3%
TTM30.8%5Y31.4%-0.6%
5Y31.4%10Y29.6%+1.8%
1.2.2. Operating Ratio

Measures how efficient Caplin Point Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.73 means that the operating costs are ₹0.73 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Caplin Point Laboratories Limited:

  • The MRQ is 0.730. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.730. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.730TTM0.7300.000
TTM0.730YOY0.723+0.007
TTM0.7305Y0.717+0.013
5Y0.71710Y0.812-0.095

1.3. Liquidity of Caplin Point Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Caplin Point Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.80 means the company has ₹5.80 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Caplin Point Laboratories Limited:

  • The MRQ is 5.800. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.800. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.800TTM5.8000.000
TTM5.800YOY6.249-0.449
TTM5.8005Y6.146-0.346
5Y6.14610Y3.686+2.461
1.3.2. Quick Ratio

Measures if Caplin Point Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Caplin Point Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 6.22 means the company can pay off ₹6.22 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Caplin Point Laboratories Limited:

  • The MRQ is 6.215. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.215. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.215TTM6.2150.000
TTM6.215YOY5.764+0.451
TTM6.2155Y5.501+0.714
5Y5.50110Y3.321+2.180

1.4. Solvency of Caplin Point Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Caplin Point Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Caplin Point Laboratories Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.13 means that Caplin Point Laboratories Limited assets are financed with 13.0% credit (debt) and the remaining percentage (100% - 13.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Caplin Point Laboratories Limited:

  • The MRQ is 0.130. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.130. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.130TTM0.1300.000
TTM0.130YOY0.130-0.001
TTM0.1305Y0.135-0.005
5Y0.13510Y0.306-0.171
1.4.2. Debt to Equity Ratio

Measures if Caplin Point Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Caplin Point Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 15.1% means that company has ₹0.15 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Caplin Point Laboratories Limited:

  • The MRQ is 0.151. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.151. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.151TTM0.1510.000
TTM0.151YOY0.153-0.002
TTM0.1515Y0.158-0.007
5Y0.15810Y0.610-0.452

2. Market Valuation of Caplin Point Laboratories Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Caplin Point Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Caplin Point Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 12.12 means the investor is paying ₹12.12 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Caplin Point Laboratories Limited:

  • The EOD is 27.562. Based on the earnings, the company is overpriced. -1
  • The MRQ is 12.118. Based on the earnings, the company is underpriced. +1
  • The TTM is 12.118. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD27.562MRQ12.118+15.444
MRQ12.118TTM12.1180.000
TTM12.118YOY17.273-5.155
TTM12.1185Y13.880-1.763
5Y13.88010Y48.750-34.869
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Caplin Point Laboratories Limited:

  • The EOD is 133.126. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 58.529. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 58.529. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD133.126MRQ58.529+74.596
MRQ58.529TTM58.5290.000
TTM58.529YOY21.090+37.439
TTM58.5295Y39.113+19.416
5Y39.11310Y105.006-65.893
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Caplin Point Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.39 means the investor is paying ₹2.39 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Caplin Point Laboratories Limited:

  • The EOD is 5.437. Based on the equity, the company is overpriced. -1
  • The MRQ is 2.391. Based on the equity, the company is underpriced. +1
  • The TTM is 2.391. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.437MRQ2.391+3.047
MRQ2.391TTM2.3910.000
TTM2.391YOY3.430-1.040
TTM2.3915Y3.091-0.700
5Y3.09110Y18.031-14.940
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Caplin Point Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--51.57951.5790%40.044+29%40.277+28%24.360+112%
Book Value Per Share--249.294249.2940%197.715+26%162.691+53%92.927+168%
Current Ratio--5.8005.8000%6.249-7%6.146-6%3.686+57%
Debt To Asset Ratio--0.1300.1300%0.130-1%0.135-4%0.306-58%
Debt To Equity Ratio--0.1510.1510%0.153-1%0.158-4%0.610-75%
Dividend Per Share--3.9633.9630%2.971+33%2.717+46%1.867+112%
Eps--49.18049.1800%39.263+25%34.325+43%21.811+125%
Free Cash Flow Per Share--10.18210.1820%32.157-68%13.224-23%8.286+23%
Free Cash Flow To Equity Per Share--6.5006.5000%26.826-76%15.249-57%8.770-26%
Gross Profit Margin--1.0001.0000%0.908+10%0.963+4%0.979+2%
Intrinsic Value_10Y_max--408.187--------
Intrinsic Value_10Y_min--105.165--------
Intrinsic Value_1Y_max--26.639--------
Intrinsic Value_1Y_min--8.945--------
Intrinsic Value_3Y_max--90.910--------
Intrinsic Value_3Y_min--28.414--------
Intrinsic Value_5Y_max--168.289--------
Intrinsic Value_5Y_min--49.422--------
Market Cap102938968928.000+56%45594173824.50045594173824.5000%51791707400.400-12%36046502420.700+26%40756677862.785+12%
Net Profit Margin--0.2570.2570%0.237+8%0.249+3%0.226+14%
Operating Margin--0.3080.3080%0.305+1%0.314-2%0.296+4%
Operating Ratio--0.7300.7300%0.723+1%0.717+2%0.812-10%
Pb Ratio5.437+56%2.3912.3910%3.430-30%3.091-23%18.031-87%
Pe Ratio27.562+56%12.11812.1180%17.273-30%13.880-13%48.750-75%
Price Per Share1355.500+56%595.950595.9500%678.200-12%472.340+26%535.510+11%
Price To Free Cash Flow Ratio133.126+56%58.52958.5290%21.090+178%39.113+50%105.006-44%
Price To Total Gains Ratio24.405+56%10.73010.7300%15.766-32%11.141-4%50.369-79%
Quick Ratio--6.2156.2150%5.764+8%5.501+13%3.321+87%
Return On Assets--0.1720.1720%0.173-1%0.190-10%0.200-14%
Return On Equity--0.2000.2000%0.202-1%0.222-10%0.314-36%
Total Gains Per Share--55.54255.5420%43.015+29%42.994+29%26.227+112%
Usd Book Value--228872400.000228872400.0000%181185600.000+26%149041665.600+54%85075802.400+169%
Usd Book Value Change Per Share--0.6190.6190%0.481+29%0.483+28%0.292+112%
Usd Book Value Per Share--2.9922.9920%2.373+26%1.952+53%1.115+168%
Usd Dividend Per Share--0.0480.0480%0.036+33%0.033+46%0.022+112%
Usd Eps--0.5900.5900%0.471+25%0.412+43%0.262+125%
Usd Free Cash Flow--9348000.0009348000.0000%29468400.000-68%12118600.800-23%7584734.400+23%
Usd Free Cash Flow Per Share--0.1220.1220%0.386-68%0.159-23%0.099+23%
Usd Free Cash Flow To Equity Per Share--0.0780.0780%0.322-76%0.183-57%0.105-26%
Usd Market Cap1235267627.136+56%547130085.894547130085.8940%621500488.805-12%432558029.048+26%489080134.353+12%
Usd Price Per Share16.266+56%7.1517.1510%8.138-12%5.668+26%6.426+11%
Usd Profit--45151200.00045151200.0000%35980800.000+25%31438680.000+44%19962499.200+126%
Usd Revenue--176007600.000176007600.0000%151561200.000+16%126957362.400+39%82739530.800+113%
Usd Total Gains Per Share--0.6670.6670%0.516+29%0.516+29%0.315+112%
 EOD+4 -4MRQTTM+0 -0YOY+22 -145Y+23 -1310Y+30 -6

3.2. Fundamental Score

Let's check the fundamental score of Caplin Point Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.562
Price to Book Ratio (EOD)Between0-15.437
Net Profit Margin (MRQ)Greater than00.257
Operating Margin (MRQ)Greater than00.308
Quick Ratio (MRQ)Greater than16.215
Current Ratio (MRQ)Greater than15.800
Debt to Asset Ratio (MRQ)Less than10.130
Debt to Equity Ratio (MRQ)Less than10.151
Return on Equity (MRQ)Greater than0.150.200
Return on Assets (MRQ)Greater than0.050.172
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Caplin Point Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,361.000
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets21,914,000
Total Liabilities2,841,300
Total Stockholder Equity18,804,800
 As reported
Total Liabilities 2,841,300
Total Stockholder Equity+ 18,804,800
Total Assets = 21,914,000

Assets

Total Assets21,914,000
Total Current Assets15,544,600
Long-term Assets6,369,400
Total Current Assets
Cash And Cash Equivalents 1,775,600
Short-term Investments 5,470,200
Net Receivables 3,940,600
Inventory 2,882,200
Other Current Assets 1,476,000
Total Current Assets  (as reported)15,544,600
Total Current Assets  (calculated)15,544,600
+/-0
Long-term Assets
Property Plant Equipment 4,893,500
Goodwill 27,700
Intangible Assets 111,700
Other Assets 582,500
Long-term Assets  (as reported)6,369,400
Long-term Assets  (calculated)5,615,400
+/- 754,000

Liabilities & Shareholders' Equity

Total Current Liabilities2,680,000
Long-term Liabilities161,300
Total Stockholder Equity18,804,800
Total Current Liabilities
Short-term Debt 42,700
Short Long Term Debt 34,100
Accounts payable 1,643,700
Other Current Liabilities 768,300
Total Current Liabilities  (as reported)2,680,000
Total Current Liabilities  (calculated)2,488,800
+/- 191,200
Long-term Liabilities
Long term Debt Total 9,300
Other Liabilities 152,000
Long-term Liabilities  (as reported)161,300
Long-term Liabilities  (calculated)161,300
+/-0
Total Stockholder Equity
Common Stock151,800
Retained Earnings 15,397,900
Accumulated Other Comprehensive Income 1,701,100
Capital Surplus 134,100
Total Stockholder Equity (as reported)18,804,800
Total Stockholder Equity (calculated)17,384,900
+/- 1,419,900
Other
Capital Stock151,800
Cash And Equivalents4,934,800
Cash and Short Term Investments 7,245,800
Common Stock Shares Outstanding 76,507
Current Deferred Revenue225,300
Liabilities and Stockholders Equity 21,914,000
Net Debt -1,723,600
Net Invested Capital 18,838,900
Net Tangible Assets 16,527,400
Net Working Capital 12,864,600
Property Plant and Equipment Gross 4,893,500
Short Long Term Debt Total 52,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-31
> Total Assets 
558,365
613,248
605,049
741,049
1,071,176
1,349,020
1,799,097
2,288,263
2,671,423
3,583,332
5,004,502
7,425,194
11,257,570
13,636,084
17,363,200
21,914,000
21,914,00017,363,20013,636,08411,257,5707,425,1945,004,5023,583,3322,671,4232,288,2631,799,0971,349,0201,071,176741,049605,049613,248558,365
   > Total Current Assets 
382,590
422,320
388,183
478,378
538,698
386,953
486,075
818,739
1,183,293
1,815,322
2,629,950
4,936,882
8,225,313
10,358,056
12,978,200
15,544,600
15,544,60012,978,20010,358,0568,225,3134,936,8822,629,9501,815,3221,183,293818,739486,075386,953538,698478,378388,183422,320382,590
       Cash And Cash Equivalents 
103,302
169,073
146,417
215,202
318,046
168,381
268,244
453,723
665,522
930,748
771,740
1,506,556
2,116,365
4,569,639
4,567,400
1,775,600
1,775,6004,567,4004,569,6392,116,3651,506,556771,740930,748665,522453,723268,244168,381318,046215,202146,417169,073103,302
       Short-term Investments 
0
0
0
0
0
0
0
0
507,576
42,000
52,226
696,231
602,298
105,350
1,704,700
5,470,200
5,470,2001,704,700105,350602,298696,23152,22642,000507,57600000000
       Net Receivables 
0
0
0
0
0
0
0
0
79,453
596,523
1,500,382
1,690,225
2,716,690
3,808,648
3,993,800
3,940,600
3,940,6003,993,8003,808,6482,716,6901,690,2251,500,382596,52379,45300000000
       Inventory 
62,147
76,190
41,539
54,991
63,760
104,245
97,895
136,638
188,149
222,949
284,556
374,451
2,382,317
1,790,019
2,273,100
2,882,200
2,882,2002,273,1001,790,0192,382,317374,451284,556222,949188,149136,63897,895104,24563,76054,99141,53976,19062,147
       Other Current Assets 
217,142
177,057
200,227
208,185
156,892
114,327
119,936
228,378
-177,954
619,625
1,521,428
2,359,644
289,719
84,400
439,200
1,476,000
1,476,000439,20084,400289,7192,359,6441,521,428619,625-177,954228,378119,936114,327156,892208,185200,227177,057217,142
   > Long-term Assets 
175,775
190,928
216,866
262,671
532,478
962,067
1,313,022
1,469,524
1,488,130
1,768,010
2,374,552
2,488,312
3,032,257
3,278,028
4,385,000
6,369,400
6,369,4004,385,0003,278,0283,032,2572,488,3122,374,5521,768,0101,488,1301,469,5241,313,022962,067532,478262,671216,866190,928175,775
       Property Plant Equipment 
139,149
165,500
194,613
251,190
402,814
839,020
1,265,428
1,427,921
1,438,606
1,538,758
1,827,094
2,344,381
2,875,552
3,119,281
2,934,300
4,893,500
4,893,5002,934,3003,119,2812,875,5522,344,3811,827,0941,538,7581,438,6061,427,9211,265,428839,020402,814251,190194,613165,500139,149
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
537
537
500
27,700
27,700500537537000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
4,410
132,439
3,340
3,330
0
0
0
0
00003,3303,340132,4394,41000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
6,022
13,723
20,651
21,083
50,137
72,386
108,000
111,700
111,700108,00072,38650,13721,08320,65113,7236,02200000000
       Long-term Assets Other 
36,626
25,428
22,253
11,482
129,664
123,047
47,594
41,603
546,688
139,842
164,545
815,749
-1
3
5,573,300
5,948,700
5,948,7005,573,3003-1815,749164,545139,842546,68841,60347,594123,047129,66411,48222,25325,42836,626
> Total Liabilities 
341,965
374,591
350,693
449,917
734,862
916,668
1,179,941
1,353,658
1,314,187
1,337,740
1,365,283
1,095,312
1,691,859
1,602,483
2,264,400
2,841,300
2,841,3002,264,4001,602,4831,691,8591,095,3121,365,2831,337,7401,314,1871,353,6581,179,941916,668734,862449,917350,693374,591341,965
   > Total Current Liabilities 
220,441
278,083
236,105
337,207
691,966
830,098
1,075,761
1,249,720
1,184,740
1,134,570
1,086,696
861,115
1,443,247
1,428,535
2,076,800
2,680,000
2,680,0002,076,8001,428,5351,443,247861,1151,086,6961,134,5701,184,7401,249,7201,075,761830,098691,966337,207236,105278,083220,441
       Short-term Debt 
0
0
0
94,554
52,034
530
500
500
12,728
2,485
2,146
2,544
373,110
178,589
9,600
42,700
42,7009,600178,589373,1102,5442,1462,48512,72850050053052,03494,554000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
12,728
2,485
2,146
2,544
364,629
170,700
5,000
34,100
34,1005,000170,700364,6292,5442,1462,48512,72800000000
       Accounts payable 
131,949
113,086
0
170,555
212,562
256,365
315,045
417,016
577,037
786,543
1,030,550
757,696
728,864
917,937
1,631,800
1,643,700
1,643,7001,631,800917,937728,864757,6961,030,550786,543577,037417,016315,045256,365212,562170,5550113,086131,949
       Other Current Liabilities 
88,492
164,997
236,105
72,098
427,370
573,203
760,216
832,204
594,975
345,542
54,000
100,875
341,273
1
380,500
768,300
768,300380,5001341,273100,87554,000345,542594,975832,204760,216573,203427,37072,098236,105164,99788,492
   > Long-term Liabilities 
121,524
96,508
114,589
112,711
42,896
86,570
104,180
103,938
129,447
203,170
278,587
234,197
248,612
173,948
187,600
161,300
161,300187,600173,948248,612234,197278,587203,170129,447103,938104,18086,57042,896112,711114,58996,508121,524
       Long term Debt Total 
0
0
0
0
0
0
0
0
7,308
4,751
3,219
2,868
13,000
5,332
11,700
9,300
9,30011,7005,33213,0002,8683,2194,7517,30800000000
       Other Liabilities 
0
0
0
0
0
0
0
0
129,626
194,203
275,368
231,329
235,612
168,616
175,900
152,000
152,000175,900168,616235,612231,329275,368194,203129,62600000000
> Total Stockholder Equity
216,400
238,657
254,355
290,836
335,779
431,424
617,386
931,939
1,354,527
2,241,970
3,638,315
6,329,094
9,479,142
11,858,216
14,839,300
18,804,800
18,804,80014,839,30011,858,2169,479,1426,329,0943,638,3152,241,9701,354,527931,939617,386431,424335,779290,836254,355238,657216,400
   Common Stock
151,100
151,100
151,100
151,100
151,100
151,100
151,100
151,100
151,100
151,153
151,207
151,261
151,286
151,286
151,600
151,800
151,800151,600151,286151,286151,261151,207151,153151,100151,100151,100151,100151,100151,100151,100151,100151,100
   Retained Earnings 
16,354
38,611
50,977
80,922
117,365
198,201
350,164
623,780
1,085,546
1,923,953
3,312,543
4,926,890
6,751,707
9,141,058
11,912,000
15,397,900
15,397,90011,912,0009,141,0586,751,7074,926,8903,312,5431,923,9531,085,546623,780350,164198,201117,36580,92250,97738,61116,354
   Accumulated Other Comprehensive Income 
-59,256
-67,405
-75,850
-87,411
-99,588
-114,826
-148,666
-234,952
0
-427,233
-613,484
-439,419
1,126,957
1,110,471
1,211,600
1,701,100
1,701,1001,211,6001,110,4711,126,957-439,419-613,484-427,2330-234,952-148,666-114,826-99,588-87,411-75,850-67,405-59,256
   Capital Surplus 
0
0
0
0
0
0
0
0
0
5,425
10,850
16,275
21,229
21,231
146,300
134,100
134,100146,30021,23121,22916,27510,8505,425000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
108,202
116,351
128,128
146,225
166,902
196,949
264,788
392,011
117,881
594,097
788,049
1,331,132
703,363
709,572
-601,600
-611,700
-611,700-601,600709,572703,3631,331,132788,049594,097117,881392,011264,788196,949166,902146,225128,128116,351108,202



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue14,667,300
Cost of Revenue-6,632,100
Gross Profit8,035,2008,035,200
 
Operating Income (+$)
Gross Profit8,035,200
Operating Expense-4,074,500
Operating Income4,521,3003,960,700
 
Operating Expense (+$)
Research Development631,900
Selling General Administrative1,369,900
Selling And Marketing Expenses0
Operating Expense4,074,5002,001,800
 
Net Interest Income (+$)
Interest Income7,800
Interest Expense-7,800
Other Finance Cost-7,800
Net Interest Income-7,800
 
Pretax Income (+$)
Operating Income4,521,300
Net Interest Income-7,800
Other Non-Operating Income Expenses0
Income Before Tax (EBT)4,513,5004,529,100
EBIT - interestExpense = 4,513,500
4,506,200
3,770,400
Interest Expense7,800
Earnings Before Interest and Taxes (EBIT)4,521,3004,521,300
Earnings Before Interest and Taxes (EBITDA)4,971,200
 
After tax Income (+$)
Income Before Tax4,513,500
Tax Provision-743,600
Net Income From Continuing Ops3,769,9003,769,900
Net Income3,762,600
Net Income Applicable To Common Shares3,762,600
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses10,706,600
Total Other Income/Expenses Net-7,8007,800
 

Technical Analysis of Caplin Point Laboratories Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Caplin Point Laboratories Limited. The general trend of Caplin Point Laboratories Limited is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Caplin Point Laboratories Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Caplin Point Laboratories Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,390 < 1,390 < 1,410.

The bearish price targets are: 1,253 > 1,243 > 1,240.

Tweet this
Caplin Point Laboratories Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Caplin Point Laboratories Limited. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Caplin Point Laboratories Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) ChartCaplin Point Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Caplin Point Laboratories Limited. The current adx is .

Caplin Point Laboratories Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Relative Strength Index (RSI) ChartCaplin Point Laboratories Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Stochastic Oscillator ChartCaplin Point Laboratories Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Commodity Channel Index (CCI) ChartCaplin Point Laboratories Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Chande Momentum Oscillator (CMO) ChartCaplin Point Laboratories Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Williams %R ChartCaplin Point Laboratories Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Average True Range (ATR) ChartCaplin Point Laboratories Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily On-Balance Volume (OBV) ChartCaplin Point Laboratories Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Caplin Point Laboratories Limited.

Caplin Point Laboratories Limited Daily Money Flow Index (MFI) ChartCaplin Point Laboratories Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Caplin Point Laboratories Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Caplin Point Laboratories Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Caplin Point Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1,361.000
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Caplin Point Laboratories Limited with someone you think should read this too:
  • Are you bullish or bearish on Caplin Point Laboratories Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Caplin Point Laboratories Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Caplin Point Laboratories Limited

I send you an email if I find something interesting about Caplin Point Laboratories Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Caplin Point Laboratories Limited.

Receive notifications about Caplin Point Laboratories Limited in your mailbox!